PUBLISHER: Grand View Research | PRODUCT CODE: 1772514
PUBLISHER: Grand View Research | PRODUCT CODE: 1772514
U.S. Bioprocess Containers Market Summary
The U.S. bioprocess containers market size was estimated at USD 1.09 billion in 2024, and is projected to reach USD 6.55 billion by 2033, growing at a CAGR of 22.1% from 2025 to 2033. The industry is driven by the increasing adoption of single-use technologies in biopharmaceutical manufacturing and the growing demand for flexible, scalable solutions for biologics and vaccine production.
Additionally, strong R&D investments and supportive regulatory frameworks further accelerate market growth.The market is primarily driven by the rapid growth of the biopharmaceutical industry, particularly the increasing demand for monoclonal antibodies, cell and gene therapies, and vaccines. Single-use bioprocess containers (SUBCs) offer flexibility, cost-efficiency, and reduced contamination risks compared to traditional stainless-steel systems, making them ideal for modern biomanufacturing. For example, the surge in mRNA vaccine production during the COVID-19 pandemic highlighted the need for scalable, disposable solutions, with companies such as Pfizer and Moderna relying heavily on single-use technologies to accelerate production timelines.
Another key factor is the shift toward personalized medicine and small-batch production, which favors single-use systems due to their adaptability and lower operational costs. Cell and gene therapies, such as CAR-T cell treatments, require specialized, sterile environments that SUBCs can provide without extensive cleaning or validation. Companies such as Thermo Fisher Scientific Inc. and Sartorius AG have expanded their portfolios to include customizable bioprocess containers tailored for these advanced therapies. Additionally, regulatory support from agencies such as the FDA, which encourages innovation in biomanufacturing, further propels market growth.
Moreover, sustainability and operational efficiency are driving adoption, as single-use containers reduce water and energy consumption compared to traditional systems. Pharmaceutical companies are under pressure to minimize their environmental footprint, and SUBCs help achieve this by eliminating the need for cleaning and sterilization. As biopharmaceutical pipelines expand and manufacturers prioritize agility, the U.S. bioprocess containers market is expected to grow steadily, supported by technological advancements and evolving industry needs.
U.S. Bioprocess Containers Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. bioprocess containers market report based on product type, application, and end use: